Viad (NYSE:VVI) Stock, Quote.Headers.trade-ideas

Viad

Viad Corp is a marketing company engaged in providing extraordinary experiences, including hospitality and leisure activities, experiential marketing, and live events. The company has three segments; Pursuit includes a collection of inspiring and unforgettable travel experiences that includes recreational attractions, hotels and lodges, food and beverage, retail, sightseeing, and ground transportation services, Spiro includes a marketing agency that partners with brands around the world to manage and elevate their experiential marketing activities, and GES Exhibitions is an exhibition services company that partners with exhibition and conference organizers as a full-service provider of strategic and logistics solutions to manage the complexity of their shows.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACHR

AREB

ASTS

AVTX

AXSM

BAOS

BDTX

BNTC

CGTX

DOMA

EDTX

EFTR

EGIO

ETON

FATH

IMBI

IRNT

JOBY

JXJT

LFLY

LICN

MPAA

MULN

NCMI

NERV

NRBO

OPEN

PINS

SONN

SRGA

SYTA

TIVC

TOVX

WULF

XPOF

Gainers


	Minerva Neurosciences, Inc.  (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.


Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

CVNA

NRGV

OSTK

SNOW

SQSP

VKTX

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.


Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday

Viad Agrees To Acquire Glacier Raft For Undisclosed Sum

Viad Corp

Vividion Therapeutics, Inc

REPLENISH NUTRIENTS HLDG by REPLENISH NUTRIENTS HLDG CORP.

Replenish Nutrients Holding Corp

Oppenheimer analyst Tyler Batory reiterates Viad (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) with a Outperform and maintains $41 price target.

Price Target

Reiteration

Analyst Ratings

Oppenheimer Reiterates Outperform on Viad, Maintains $41 Price Target

B. Riley Securities analyst Bryan Maher reiterates Viad (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) with a Buy and lowers the price target from $46 to $42.

B. Riley Securities Reiterates Buy on Viad, Lowers Price Target to $42

Oppenheimer analyst Tyler Batory reiterates Viad (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) with a Outperform and lowers the price target from $43 to $41.

Oppenheimer Reiterates Outperform on Viad, Lowers Price Target to $41

WIIM

Viad shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 revenue guidance above estimates.

Our guidance for Viad consolidated, Pursuit, and GES is below. Pursuit's guidance range assumes Jasper National Park re-opens on September 3 and is subject to change due to the evolving wildfire situation. We will update as appropriate during the third quarter.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">(in millions)</td>
<td colspan="1" rowspan="1">Third Quarter</td>
<td colspan="1" rowspan="1">Full Year</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Viad Consolidated</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">$418 to $463</td>
<td colspan="1" rowspan="1">Up high-single digits</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$87 to $105</td>
<td colspan="1" rowspan="1">$151 to $176</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cash flow from Operations</td>
<td colspan="1" rowspan="1">$70 to $80</td>
<td colspan="1" rowspan="1">$80 to $100</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital Expenditures</td>
<td colspan="1" rowspan="1">
$14 to $19
(including growth capex of ~$4)
</td>
<td colspan="1" rowspan="1">
$65 to $70
(including growth capex of ~$20)
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Effective Tax Rate</td>
<td colspan="1" rowspan="1">11% to 12%</td>
<td colspan="1" rowspan="1">28% to 29%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Pursuit</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">$160 to $185</td>
<td colspan="1" rowspan="1">In line with prior year</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$75 to $90</td>
<td colspan="1" rowspan="1">$80 to $95</td>
</tr>
<tr>
<td colspan="1" rowspan="1">GES</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">$258 to $278</td>
<td colspan="1" rowspan="1">Up low-double digits</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$15 to $19</td>
<td colspan="1" rowspan="1">$85 to $95</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Viad Sees Q3 2024 Revenue $418M-$463M Vs $359.2M Estimate

Viad (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.82 by 18.29 percent. The company reported quarterly sales of $378.538 million which beat the analyst consensus estimate of $359.276 million by 5.36 percent. This is a 18.18 percent increase over sales of $320.311 million the same period last year.

Earnings

Earnings Beats

Viad Q2 2024 Adj. EPS $0.97 Beats $0.82 Estimate, Sales $378.538M Beat $359.276M Estimate

Viad Corp to Expand Pursuit's Collection With $18M Acquisition of Jasper SkyTram; Expects $4M Revenue Addition; Total Payment of C$25M

2024 Outlook
Our guidance for Viad consolidated, Pursuit, and GES is as follows:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">(in millions)</td>
<td colspan="1" rowspan="1">Second Quarter</td>
<td colspan="1" rowspan="1">Full Year</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Viad Consolidated</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">$352 to $377</td>
<td colspan="1" rowspan="1">Up high-single to low-double digits</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$51 to $59</td>
<td colspan="1" rowspan="1">$171 to $191</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cash flow from Operations</td>
<td colspan="1" rowspan="1">$35 to $45</td>
<td colspan="1" rowspan="1">$120 to $140</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital Expenditures</td>
<td colspan="1" rowspan="1">
$20 to $25
(including growth capex of ~$5)
</td>
<td colspan="1" rowspan="1">
$65 to $70
(including growth capex of ~$20)
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Pursuit</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">$92 to $97</td>
<td colspan="1" rowspan="1">Up mid-single digits</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$20 to $24</td>
<td colspan="1" rowspan="1">$105 to $115</td>
</tr>
<tr>
<td colspan="1" rowspan="1">GES</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">$260 to $280</td>
<td colspan="1" rowspan="1">Up low-double digits</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$34.5 to $38.5</td>
<td colspan="1" rowspan="1">$80 to $90</td>
</tr>
</tbody>
</table>
</figure>

Viad Sees Q2 Revenue $352M-$377M Vs $328.97M Est.; FY24 Revenue Up High-Single To Low-Double Digits

Viad (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) reported quarterly losses of $(1.13) per share which missed the analyst consensus estimate of $(1.07) by 5.61 percent. This is a 1.74 percent increase over losses of $(1.15) per share from the same period last year. The company reported quarterly sales of $273.497 million which beat the analyst consensus estimate of $269.516 million by 1.48 percent. This is a 4.87 percent increase over sales of $260.791 million the same period last year.

Earnings Misses

Viad Q1 2024 Adj EPS $(1.13) Misses $(1.07) Estimate, Sales $273.497M Beat $269.516M Estimate

Viad Says It Maintains Its Previously Disclosed Outlook For Year Ending Dec. 31, 2024; Launched Process To Effect Potential Repricing Of Credit Spread On Its $400M Term Loan B

B. Riley Securities analyst Bryan Maher reiterates Viad (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) with a Buy and raises the price target from $46 to $50.

B. Riley Securities Reiterates Buy on Viad, Raises Price Target to $50

Viad Sees FY24 Revenue Up High-Single To Low-Double Digits

Viad Sees Q1 2024 Revenue $260M-$284M Vs $268.610M Est.

Viad (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.76) by 3.95 percent. The company reported quarterly sales of $291.68 million which beat the analyst consensus estimate of $277.12 million by 5.26 percent. This is a 17.60 percent increase over sales of $248.03 million the same period last year.

Viad Q4 2023 Adj EPS $(0.79) Misses $(0.76) Estimate, Sales $291.68M Beat $277.12M Estimate

AFRM

AIRC

APDN

ARES

AXTA

BILL

BIOX

CIGI

CIVB

CLSK

CPRI

CRIS

CTLP

CTRE

CYBR

DOCS

DXCM

EGAN

EMKR

EXPE

FARM

FLUX

FORR

GTES

IBEX

IIIV

ILMN

IRMD

JRSH

KVUE

LADR

LITE

LIVE

LPTH

LQDT

LSPD

LTRX

LVWR

NGVC

OMCL

ONTO

PATK

PCTY

PEAK

PECO

PETS

PINE

PODC

Earnings Scheduled For February 8, 2024

Oppenheimer analyst Tyler Batory maintains Viad (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) with a Outperform and raises the price target from $36 to $43.

Oppenheimer Maintains Outperform on Viad, Raises Price Target to $43

Viad Corp shares are trading higher after the company reported better-than-expected Q3 financial results.

Viad (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.27 by 17.32 percent. This is a 0.68 percent increase over earnings of $1.48 per share from the same period last year. The company reported quarterly sales of $365.90 million which beat the analyst consensus estimate of $354.14 million by 3.32 percent. This is a 4.40 percent decrease over sales of $382.72 million the same period last year.

Viad Q3 EPS 2023 Adj $1.49 Beats $1.27 Estimate, Sales $365.90M Beat $354.14M Estimate

RDFN

REFR

REGN

RLAY

RMAX

ROCK

RYAN

SABR

SAMG

SBAC

SBUX

SHAK

SHEL

SHOP

SLQT

SMLP

SNDX

SPGI

SPXC

SRCL

STEM

STGW

STRA

SWKS

TALK

TCPC

TEAM

THRY

TMST

TPIC

TRGP

TRUP

TSLX

TTSH

TWIN

UDMY

UEIC

UNIT

UPBD

UPLD

VCTR

VIAV

VIRT

VITL

VRNA

VTLE

VXRT

WLDN

WLKP

XRAY

YELP

ZEUS

Earnings Scheduled For November 2, 2023

B. Riley Securities analyst Bryan Maher maintains Viad (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) with a Buy and raises the price target from $13 to $14.5.

B. Riley Securities Maintains Buy on Viad, Raises Price Target to $14.5

Viad Corp (VVI) Q2 2024 Earnings Call Transcript

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Viad

Viad (VVI) Forecast

Viad (NYSE:VVI) Stock, Quote.Headers.trade-ideas